Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01369-20.
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer is transported through the secretory pathway to the infected cell surface and onto virion particles. In the Golgi, the gp160 Env precursor is modified by complex sugars and proteolytically cleaved to produce the mature functional Env trimer, which resists antibody neutralization. We observed mostly uncleaved gp160 and smaller amounts of cleaved gp120 and gp41 Envs on the surface of HIV-1-infected or Env-expressing cells; however, cleaved Envs were relatively enriched in virions and virus-like particles (VLPs). This relative enrichment of cleaved Env in VLPs was observed for wild-type Envs, for Envs lacking the cytoplasmic tail, and for CD4-independent, conformationally flexible Envs. On the cell surface, we identified three distinct populations of Envs: (i) the cleaved Env was transported through the Golgi, was modified by complex glycans, formed trimers that cross-linked efficiently, and was recognized by broadly neutralizing antibodies; (ii) a small fraction of Env modified by complex carbohydrates escaped cleavage in the Golgi; and (iii) the larger population of uncleaved Env lacked complex carbohydrates, cross-linked into diverse oligomeric forms, and was recognized by poorly neutralizing antibodies. This last group of more "open" Env oligomers reached the cell surface in the presence of brefeldin A, apparently bypassing the Golgi apparatus. Relative to Envs transported through the Golgi, these uncleaved Envs were counterselected for virion incorporation. By employing two pathways for Env transport to the surface of infected cells, HIV-1 can misdirect host antibody responses toward conformationally flexible, uncleaved Env without compromising virus infectivity. The envelope glycoprotein (Env) trimers on the surface of human immunodeficiency virus type 1 (HIV-1) mediate the entry of the virus into host cells and serve as targets for neutralizing antibodies. The cleaved, functional Env is incorporated into virus particles from the surface of the infected cell. We found that an uncleaved form of Env is transported to the cell surface by an unconventional route, but this nonfunctional Env is mostly excluded from the virus. Thus, only one of the pathways by which Env is transported to the surface of infected cells results in efficient incorporation into virus particles, potentially allowing the uncleaved Env to act as a decoy to the host immune system without compromising virus infectivity.
人类免疫缺陷病毒 1 型(HIV-1)包膜糖蛋白(Env)三聚体通过分泌途径运输到感染细胞表面,并进入病毒粒子。在高尔基体中,gp160Env 前体被复杂的糖修饰,并通过蛋白水解切割产生成熟的功能性 Env 三聚体,该三聚体抵抗抗体中和。我们观察到 HIV-1 感染或 Env 表达细胞表面存在大量未切割的 gp160 和较少量的切割 gp120 和 gp41Env;然而,切割的 Env 在病毒样颗粒(VLPs)中相对富集。这种切割的 Env 在 VLPs 中的相对富集可观察到野生型 Env、缺乏细胞质尾巴的 Env 和 CD4 非依赖性、构象灵活的 Env。在细胞表面,我们鉴定出三种不同的 Env 群体:(i)切割的 Env 通过高尔基体运输,被复杂糖修饰,形成有效地交联的三聚体,并被广泛中和抗体识别;(ii)一小部分被复杂碳水化合物修饰的 Env 在高尔基体中逃避切割;和(iii)未切割的 Env 较大群体缺乏复杂碳水化合物,交联成多种寡聚形式,并被中和能力较差的抗体识别。最后一组更多的“开放”Env 寡聚体在布雷菲德菌素 A 的存在下到达细胞表面,显然绕过了高尔基体。与通过高尔基体运输的 Env 相比,这些未切割的 Env 被选择用于病毒粒子的掺入。通过采用两种途径将 Env 运输到感染细胞的表面,HIV-1 可以将宿主的抗体反应误导到构象灵活的未切割的 Env 上,而不损害病毒感染力。人类免疫缺陷病毒 1 型(HIV-1)表面的包膜糖蛋白(Env)三聚体介导病毒进入宿主细胞,并作为中和抗体的靶标。切割的、功能性的 Env 从感染细胞的表面被整合到病毒粒子中。我们发现,Env 的一种未切割形式通过一种非传统途径被运输到细胞表面,但这种无功能的 Env 大部分被排除在病毒之外。因此,Env 被运输到感染细胞表面的途径之一导致有效地被整合到病毒粒子中,这可能使未切割的 Env 作为宿主免疫系统的诱饵,而不损害病毒感染力。